Prednisone Pediatric Dose by Weight and Condition

Prednisone doses for children vary widely depending on the condition being treated, but most fall in the range of 0.25 to 2 mg per kilogram of body weight per day. A child with an asthma flare might get 1 to 2 mg/kg daily for a few days, while a child with nephrotic syndrome could start at 2 mg/kg (or 60 mg per square meter of body surface area) daily for several weeks. The dose, the schedule, and the duration all shift depending on whether the goal is to stamp out a brief inflammatory episode or manage a chronic disease over months, and the details matter more in children than in adults because a growing body responds to steroids differently.

How Pediatric Doses Are Calculated

Most pediatric prednisone prescriptions are written by body weight, expressed as milligrams per kilogram per day. This is straightforward: weigh the child, multiply, and you have a daily dose. But there is a second method used in certain diseases, especially nephrotic syndrome and childhood cancers, which calculates the dose based on body surface area (BSA), expressed as milligrams per square meter per day. These two approaches do not always land on the same number.

A study comparing the two methods in children with nephrotic syndrome found that the weight-based dose was about 15% lower than the BSA-based dose in children weighing under 30 kilograms. The discrepancy shrank as children got heavier, but for smaller kids the gap was meaningful. The median ratio of weight-based to BSA-based dose was 0.85, meaning the weight-based calculation consistently delivered less drug than the surface-area formula would have prescribed.¹

Does that gap actually change outcomes? A follow-up study of 56 children treated with weight-based dosing found that the initial response to prednisone was the same regardless of whether the child was technically “underdosed” relative to the BSA calculation. However, children whose weight-based dose fell furthest short of the BSA-based dose were more likely to relapse frequently afterward. Those who frequently relapsed had a relative underdosing percentage of about 17%, compared with roughly 9% in children who relapsed less often.² So the choice between weight-based and BSA-based dosing is not purely academic, especially for younger, smaller children with conditions requiring prolonged steroid courses.

Doses for Acute Asthma

For a child showing up to an emergency department or urgent care with an asthma flare, prednisone is one of the most commonly used oral steroids. The typical dose is 1 to 2 mg/kg per day, capped at 60 mg, for about five days.³ This short burst is designed to calm airway inflammation quickly enough to keep the child out of the hospital.

Dexamethasone has become an increasingly popular alternative in this setting, often given at 0.6 mg/kg (maximum 16 mg) for just one or two days instead of five days of prednisone. A randomized trial comparing the two approaches in children aged 2 to 18 found similar results in symptom improvement and relapse rates, with dexamethasone offering the advantage of fewer doses and reportedly fewer side effects like vomiting.⁴ Both drugs reduce hospital admissions effectively, and the practical choice often comes down to which one a child will actually swallow and keep down. Prednisone liquid formulations taste notoriously bitter, which matters a great deal when your patient is a nauseated four-year-old.

Doses for Croup

Croup is another condition where a short steroid course is standard in children. A single dose of dexamethasone at 0.6 mg/kg has been the traditional go-to, but prednisone works comparably. A community-based randomized trial found no meaningful differences in outcomes between one dose of dexamethasone at 0.6 mg/kg and a three-day course of prednisolone at 2 mg/kg once daily. Croup symptoms lasted an average of about two to three days in both groups.⁵

Even lower doses appear to work. A randomized trial comparing prednisolone at 1 mg/kg, low-dose dexamethasone at 0.15 mg/kg, and standard dexamethasone at 0.6 mg/kg found no significant differences in any outcome measure for mild to moderate croup.⁶ A larger trial confirmed that both low-dose dexamethasone and prednisolone were noninferior to standard-dose dexamethasone, with re-attendance rates hovering around 18 to 22% across all groups.⁷ For croup, in other words, the steroid dose does not need to be as high as it does for asthma, and a single dose often suffices.

Doses for Nephrotic Syndrome

Nephrotic syndrome, a kidney condition that causes children to lose large amounts of protein in their urine, requires a much longer and more structured steroid course than acute respiratory conditions. The initial treatment typically involves daily oral prednisolone at 60 mg/m² (or 2 mg/kg, capped at 60 mg/day) for four to six weeks, followed by alternate-day dosing at 40 mg/m² (or 1.5 mg/kg, capped at 40 mg) for another four to six weeks. The total initial course runs 8 to 12 weeks.⁸

The question of whether a longer initial course prevents relapses has been studied directly. A randomized trial assigned 71 children to either a “standard” 8-week course (4 weeks daily, then 4 weeks alternate-day) or a “long” 12-week course (6 weeks daily, then 6 weeks alternate-day), using the same dose levels. After two years, roughly half the children in the longer-course group maintained sustained remission, compared with only about one in five in the standard group. The longer course did not increase the rate of severe steroid side effects.⁹ This is one reason many pediatric nephrologists now lean toward the 12-week initial course, though guidelines note that extending treatment beyond 12 weeks does not add further benefit.

Doses for Juvenile Arthritis and Other Chronic Conditions

Children with severe juvenile rheumatoid arthritis sometimes need prednisone when other anti-inflammatory drugs have not brought the disease under control. In this context, the dose range is typically lower than what is used for nephrotic syndrome: 0.25 to 1 mg/kg per day, given as a single morning dose or split into divided doses for more severe flares.¹⁰ The idea is to use as little steroid as possible and for as short a period as possible, often as a “bridge” to give slower-acting medications time to kick in. Alternate-day dosing, where the child takes prednisone every other morning instead of daily, is preferred whenever the disease allows it, because it causes less growth suppression and fewer metabolic side effects.

In inflammatory bowel disease, childhood cancers, and organ transplant situations, prednisone doses and durations vary even more widely, but the same principle applies: clinicians aim for the lowest effective dose and the shortest practical course, stepping down as soon as the underlying condition permits.

Growth Suppression

The side effect that worries most parents is stunted growth, and the concern is justified. Daily prednisone therapy slows linear growth in children. A study of children with chronic liver disease found that daily steroid use significantly reduced growth velocity, while switching to alternate-day dosing actually allowed growth to accelerate, presumably because the underlying disease was still controlled but the steroid’s growth-suppressing effect was reduced.¹¹

The effects are not always reversible, and they are not equal between sexes. A long-term follow-up of children with cystic fibrosis who had received alternate-day prednisone found that boys treated with prednisone ended up about 4 centimeters shorter as adults than boys who received placebo, a gap that persisted even years after the drug was stopped. Girls, by contrast, showed catch-up growth two to three years after discontinuation, and the height difference eventually disappeared.¹²

For children with nephrotic syndrome who relapse frequently and therefore accumulate high total steroid exposure over years, the growth impact is dose-dependent. A study tracking children over their treatment courses found that those with four or more relapses experienced significantly greater declines in height scores than those who relapsed less often. Higher cumulative doses correlated with more growth loss, and predicted adult height also decreased with longer steroid exposure.¹³ This is one of the key reasons clinicians are so eager to find steroid-sparing alternatives for children who relapse repeatedly.

Metabolic and Cardiovascular Effects

Growth is not the only concern with prolonged steroid use. A controlled study following children with frequently relapsing nephrotic syndrome over five years found striking rates of metabolic problems. After three years of intermittent prednisone treatment, about a quarter of patients had impaired fasting glucose and nearly nine out of ten had elevated LDL cholesterol. By five years, all patients had high total cholesterol, about a third had impaired fasting glucose, and 40% had developed hypertension.¹⁴ These numbers are sobering, and they underline why children on long-term prednisone need regular monitoring of blood pressure, blood sugar, and lipids, not just kidney function.

Behavioral and Mood Changes

Parents often notice personality changes in children on prednisone: irritability, mood swings, trouble sleeping, hyperactivity, or tearfulness. These are real and well-documented. A study of children being treated for inflammatory bowel disease found that those on corticosteroids were rated as having more emotional and behavioral problems than controls, with sleep disruption partly explaining some of the changes.¹⁵ The effects tended to be more prominent in children with Crohn’s disease than in those with ulcerative colitis, for reasons that are not entirely clear.

Serious psychiatric events like psychosis are uncommon but not unheard of. In a large trial of children with acute lymphoblastic leukemia receiving high-dose steroids, about 6% of those on dexamethasone experienced behavioral toxicity including severe mood swings, depression, and violence toward themselves or others. Three cases of delusional psychosis occurred, all of which resolved after switching to prednisolone.¹⁶ This particular study compared dexamethasone to prednisolone, and the psychiatric side effects were more common with dexamethasone at the doses used in cancer treatment. At the lower doses used for asthma or croup, these severe reactions are rare, but parents should know that mood changes are a recognized side effect and that they typically resolve once the steroid is stopped.

A study of boys with Duchenne muscular dystrophy on long-term daily prednisone found that while average behavioral scores fell within normal limits, more than 30% of boys on prednisone scored in the borderline or clinical range for externalizing behaviors such as aggression and rule-breaking.¹⁷ The behavioral effects of steroids in children remain an under-recognized burden for families managing chronic conditions.

Tapering and Adrenal Recovery

When a child has been on prednisone for more than a week or two, the body’s adrenal glands begin to slow their own cortisol production. Stopping the drug abruptly can leave the child without enough cortisol to handle everyday stress, let alone illness or injury. This is why prednisone courses lasting longer than a couple of weeks almost always require a gradual taper rather than an abrupt stop.

A common approach for chronic use is to reduce the dose by 10 to 20% every one to three weeks, with careful monitoring for signs of adrenal insufficiency such as fatigue, nausea, low blood pressure, or poor appetite. When the dose drops near the level the body would normally produce on its own, clinicians often switch to hydrocortisone, which has a shorter duration of action and more closely mimics the body’s natural cortisol rhythm. Checking cortisol levels during the taper helps identify children whose adrenal glands are slow to wake back up and who may need supplemental hydrocortisone coverage during illnesses.¹⁸

The risk of adrenal suppression is substantial. Studies in children on replacement-level steroid therapy report that between roughly a third and 60% still show signs of adrenal insufficiency when tested at least a month after stopping treatment.¹⁹ Families need to be aware that a child who has recently finished a steroid course may need “stress dosing” of hydrocortisone if they become acutely ill, have surgery, or experience significant physical stress, even if the prednisone itself was stopped weeks ago.

Vaccinations While on Prednisone

Whether a child on prednisone can receive vaccines depends on the dose and duration. Short bursts for asthma or croup, lasting under two weeks, generally do not require any changes to the vaccination schedule. Longer courses at immunosuppressive doses change the picture substantially.

Inactivated vaccines (like flu shots, tetanus, or COVID vaccines) are considered safe for children on immunosuppressive medications when their disease is stable, though the immune response may be blunted and extra doses might be needed.²⁰ Live vaccines, however, are a different story. Live-attenuated vaccines such as MMR, varicella, and the nasal flu spray should be avoided in children on immunosuppressive steroid doses.²¹ The general threshold used by most guidelines is prednisone at 2 mg/kg per day (or 20 mg/day for children over 10 kg) for 14 days or longer. Below that threshold, or after a waiting period once the drug is stopped, live vaccines can usually be given. Your child’s doctor will know the specifics, but it is worth bringing up the vaccination schedule proactively if your child is starting a prednisone course lasting more than a week or two.

The Taste Problem

This may sound trivial compared to adrenal suppression and growth effects, but in practice, getting prednisone into a young child can be one of the biggest challenges families face. Oral liquid prednisone is intensely bitter, and children regularly spit it out, gag, or vomit.²² This is not a minor issue: a dose that does not stay down does not count. Mixing the liquid with a small amount of something strongly flavored (chocolate syrup, juice concentrate) can help, and pharmacists can sometimes compound prednisone into a more palatable suspension. Prednisolone (the active form prednisone converts to in the body) is available in some countries as an oral disintegrating tablet, which is somewhat less offensive. For children who receive medication through a nasogastric tube, drug losses during tube administration can range from about 4 to 36% depending on the volume used to flush the tube and the formulation, which means the actual delivered dose may be meaningfully less than what was drawn up.²³

Why Some Children Respond Differently

Even at the same dose per kilogram, children do not all respond to prednisone the same way. Some achieve remission in days; others take weeks or never fully respond. Part of this variation is genetic. The glucocorticoid receptor gene (NR3C1) has several common variants that affect how sensitive a child’s cells are to the drug. One study found that a particular genetic variant (the GTA haplotype) was more common in children who responded to prednisone within the first seven days than in those who responded later.²⁴

Another piece of the puzzle involves the ABCB1 gene, which codes for a protein that pumps drugs out of cells. Variations in this gene have been linked to steroid resistance in children with nephrotic syndrome, potentially because the pump clears prednisone from target cells before it can work properly.²⁵ Pharmacogenomic testing is not yet part of routine clinical practice for prednisone dosing, but it helps explain why two children with the same diagnosis and same body weight can have very different responses to identical prescriptions. Absorption also varies between children: early pharmacokinetic work showed that prednisone peaks in the blood one to two hours after ingestion, with a half-life averaging about 132 minutes, but some children showed marked variability in both absorption and metabolism.

Infection Risk During Treatment

Prednisone at immunosuppressive doses blunts the immune system, which is exactly the point when treating autoimmune or inflammatory conditions, but it also leaves children more vulnerable to infections. For children on high-dose or long-term steroids, particularly those also taking other immunosuppressive drugs, guidelines recommend screening and sometimes prophylaxis against specific infections including varicella zoster virus, tuberculosis, and Pneumocystis jirovecii (a fungal lung infection that can be dangerous in immunosuppressed patients).²⁶ A child on a short burst for asthma does not need any of this, but a child on months of prednisone for nephrotic syndrome or arthritis might. If your child has not had chickenpox or the varicella vaccine and is about to start immunosuppressive steroids, that vaccine should ideally be given beforehand, since it is a live vaccine and cannot be given safely once high-dose prednisone is underway.